Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Drugs giant AstraZeneca faces a landmark High Court battle over accusations that some doses of its Covid-19 vaccine were 'defective' and claims of its efficacy were 'vastly overstated'. Two test ...

As consumers struggle with soaring drug prices, AstraZeneca Q3 profits doubled to $1.37 billion. The pharmaceutical industry is enjoying record profits while simultaneously pursuing lawsuits ...

The DOJ announced a $25 million agreement on November 9, 2023, requiring Apple to pay $6.75 million in civil penalties and create an $18.25 million backpay fund for potential discrimination claimants.

(Reuters) -Drugmaker AstraZeneca said on Tuesday its cancer drug Imfinzi given along with chemoradiotherapy (CRT) failed to meet its main goal in a late-stage trial to treat unresectable, Stage 3 ...

Shares of AstraZeneca rose as much as 4.2% in early trade after the company raised its full-year guidance for core earnings per share and total revenue excluding Covid-19 medicines after beating ...

NEW YORK -- Major League Baseball avoided a possible U.S. Supreme Court challenge to its antitrust exemption when it settled a federal lawsuit and two in New York State court filed by minor league ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...